Open research questions in Advanced Proteomics Techniques and Applications
120 unresolved questions extracted from the limitations and future-work sections of 314 Advanced Proteomics Techniques and Applications papers in our library. Each links back to the study that raised it.
What the literature leaves open
As the most prevalent neurodegenerative disorder worldwide, Alzheimer's disease (AD) remains incompletely understood at the proteome level.
How tumors generate a cryptic "dark" proteome absent from healthy tissues, and whether it can be reversibly activated, remains unclear.
Oncogenic fusions induce an extensive cancer-restricted cryptic proteome in Ewing sarcoma · 2026 · DOIPost-translational modifications (PTMs) are key regulators of protein function and cellular processes; however, the overall principles of PTM co-regulation and crosstalk remain to be fully understood.
MoDPA: Inferring Modification-dependent Protein Associations from Uniformly Reprocessed Mass Spectrometry · 2026 · DOIMany liquid chromatography-mass spectrometry (LC-MS) studies have compared formalin-fixed paraffin-embedded (FFPE) tissues with matched fresh-frozen (FF) tissues to examine the effect of preservation techniques on the proteome; however, few studies have included the phosphoproteome.
Overlap of Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Matched Tissues for Proteomics and Phosphoproteomics · 2025 · DOIOverall, this study provides valuable transcriptome data resources and the comprehensive muscle protein information detected to date for further study into the processing characteristic of early postmortem fish muscle, as well as a spectral library for data-independent acquisition and data processing.
Postmortem Muscle Proteome Characteristics of Silver Carp ( Hypophthalmichthys molitrix ): Insights from Full-Length Transcriptome and Deep 4D Label-Free Proteomic · 2024 · DOISmall sample size. No correction for multiple testing due to the exploratory nature and small sample size of this pilot study. The need for rigorous validation in larger cohorts.
Rigorous validation of the implicated biomarkers in larger cohorts. Integration of multi-analyte biomarker panels with clinical and imaging data. Exploration of the potential of serum-based biomarkers for advancing lung cancer diagnostics.
The limitations of affinity-based assays, such as protein binding affected by other binding partners or autoantibodies. The developmental overhead associated with hundreds of proteins. The need for precise definition of the measurand for standardization purposes.
Next-generation proteomics in medical laboratories: metrologically sound quantitative protein tests vs. innovative and personalized proteome patterns · 2026 · DOIFurther development of next-generation proteomics technologies. Investigation of the potential of these technologies in large-scale population studies. Standardization of proteomics measurements to ensure precise definition of the measurand.
Next-generation proteomics in medical laboratories: metrologically sound quantitative protein tests vs. innovative and personalized proteome patterns · 2026 · DOITNBC is a highly aggressive and clinically challenging breast cancer subtype. Chemotherapy resistance is a major challenge in the treatment of TNBC. There is a need for more effective treatment strategies for TNBC.
Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer · 2026 · DOIThe clinical utility of integrated proteogenomic biomarkers for predicting chemotherapy response in TNBC remains underexplored. There is a need for more effective treatment strategies for TNBC.
Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer · 2026 · DOISpectral overlap typically limits simultaneous detection to ~10 proteins in conventional flow cytometry. LC-MS/MS-based SCP is currently limited by relatively low throughput. MALDI-based strategies in SCP applications are largely due to insufficient sensitivity for protein analysis.
Evolution in single-cell proteomics drives new frontiers in cancer biology and precision medicine · 2026 · DOITo advance LC-MS/MS-based methodologies for large-scale proteome profiling at the single-cell level. To explore the potential of deep visual proteomics (DVP) for spatially resolved proteome profiling.
Evolution in single-cell proteomics drives new frontiers in cancer biology and precision medicine · 2026 · DOIthroughout limited Data availability statement The data analyzed in this study is subject to the following licenses/restrictions: The datasets analyzed in this study are not Frontiers in Cardiovascular Medicine 08 frontiersin.
Identification of a plasma proteomic signature associated with sudden cardiac death risk in the UK biobank · 2026 · DOIBreast cancer is a complex disease. Current treatment strategies have limitations. There is a need to explore alternative therapeutic options with improved efficacy.
Integrated data-independent acquisition and thermal proteome profiling for proteomic characterization of lamotrigine-treated MCF-7 cells · 2026 · DOIFurther evaluation of lamotrigine in breast cancer is needed. The integrated mass spectrometry-based proteomic strategy may be applied to other diseases.
Integrated data-independent acquisition and thermal proteome profiling for proteomic characterization of lamotrigine-treated MCF-7 cells · 2026 · DOIPrevious nacre proteomics have remained largely qualitative. There is a lack of understanding of the abundance and fraction association of individual shell matrix proteins.
Quantitative Proteomic Profiling of Pinctada fucata Shell Nacre Defines a Solubility-Based Type Classification of Shell Matrix Proteins · 2026 · DOIThis approach overcomes a key limitation of existing MS-based MRD assays by enabling peptide target discovery in patients without archived serum but with available BM sequencing.
Enabling blood-based mass spectrometry MRD detection in multiple myeloma without archived serum samples. · 2026 · DOIThe current markers of systemic inflammation are nonspecific. There is a need for more specific markers of systemic inflammation. There is a need for a better understanding of proteome dynamics in critically ill patients.
Accurate protein quantification remains a challenge in mass-spectrometry-based proteomics. Prior methods have limitations in terms of accuracy and precision.
Tamm-Horsfall protein contamination. The underexplored proteomic composition of P20 fractions. The need for optimized THP removal strategies to enhance mass spectrometry resolution.
Comparative mass spectrometry analysis of high and low centrifugation extracellular vesicle (EV) pellets from healthy urine following Tamm-Horsfall protein removal · 2026 · DOIMass spectrometry-based bottom-up proteomics cannot accurately identify proteoforms, including their combinatorial post-translational modifications. The need for a more precise proteoform landscape of the protein corona to advance nanomedicine applications.
Integrated top-down and bottom-up proteomics enables precise characterization of proteoforms within the protein corona · 2026 · DOIThe study identifies a gap in the accuracy of ion mobility measurements in the context of mass spectral library building and searching. The study identifies a need for a standardized calibration system for trapped ion mobility spectrometry (TIMS).
Evaluation of TIMS-derived peptide mobility measurements: calibration strategy and MS1/MS2 discrepancies · 2026 · DOIWhile synchro-PASEF has demonstrated competitive identification depth for global protein abundance samples compared to conventional dia-PASEF, its performance for phosphoproteomics - where the precursor ion cloud is characteristically broader and bimodally distributed - has not been evaluated.
Systematic optimization and benchmarking of synchro-PASEF for high-throughput phosphoproteome profiling · 2026 · DOIThe RPLC-MS/MS conducted on the Orbitrap Exploris 480 is limited by ion decay, inefficient dissociation by HCD, and spectral overlap among resulting fragment ions. The scope of magnetic beads and binding conditions explored is limited. A more thorough examination of additives present during protein binding would likely yield improved capture and recovery of low abundance proteoforms.
Most-cited papers in Advanced Proteomics Techniques and Applications
- Mass spectrometry-based proteomics · Nature · 2003 · 5,820 citations
- Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry · Nature · 2002 · 2,920 citations
- A subcellular map of the human proteome · Science · 2017 · 2,550 citations
- Towards a proteome-scale map of the human protein–protein interaction network · Nature · 2005 · 2,482 citations
- An atlas of substrate specificities for the human serine/threonine kinome · Nature · 2023 · 748 citations
- Ultra‐high sensitivity mass spectrometry quantifies single‐cell proteome changes upon perturbation · Molecular Systems Biology · 2022 · 523 citations
- EFI-EST, EFI-GNT, and EFI-CGFP: Enzyme Function Initiative (EFI) Web Resource for Genomic Enzymology Tools · Journal of Molecular Biology · 2023 · 450 citations
- Ultra-fast label-free quantification and comprehensive proteome coverage with narrow-window data-independent acquisition · Nature Biotechnology · 2024 · 330 citations
- Mass-spectrometry-based proteomics: from single cells to clinical applications · Nature · 2025 · 325 citations
- Streamlined single-cell proteomics by an integrated microfluidic chip and data-independent acquisition mass spectrometry · Nature Communications · 2022 · 233 citations
Most recent work
- A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology · Nature Medicine · 2026
- Impact of protein degradation and cell growth on mammalian proteomes · bioRxiv · 2026
- Encoded and non-genetic alternative protein variants expand human functional proteome · bioRxiv · 2026
- A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia · Nature Medicine · 2026
- Accurate quantification in proteomics with QuantUMS · Nature Biotechnology · 2026
- JMod: Joint modeling of mass spectra for empowering multiplexed DIA proteomics · bioRxiv · 2026
- Population scale proteomics enables adaptive digital twin modelling in sepsis · medRxiv · 2026
- Decoding Cardiovascular Disease Through Spatial Proteomics · Circulation Research · 2026
- Cryptic binding sites are detected but not ranked: coverage, conversion, and the limits of detector consensus · bioRxiv · 2026
- Alpha&ESMhFolds: An Updated Web Server for the Comparison, Evaluation, and Annotation of Human AlphaFold2 and ESMFold Models · Journal of Molecular Biology · 2026
Find a gap in your own Advanced Proteomics Techniques and Applications sub-topic
This page shows what the Advanced Proteomics Techniques and Applications literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →